PSMA PET/CT guided intensification of therapy in patients at risk of advanced prostate cancer (PATRON): a pragmatic phase III randomized controlled trial

Overview of attention for article published in BMC Cancer, March 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter: 3 tweeters

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 20 Mendeley

Summary Twitter Dimensions citations

So far, Altmetric has seen 3 tweets from 3 users, with an upper bound of 4,720 followers.

RT @ResearchPCC: "PSMA PET/CT guided intensification of therapy in patients at risk of advanced prostate cancer (PATRON): a pragmatic phase…

22 Mar 2022

Reply Retweet Favourite

"PSMA PET/CT guided intensification of therapy in patients at risk of advanced prostate cancer (PATRON): a pragmatic phase III randomized controlled trial" Proud to support this important work with funds from @MovemberCA https://t.co/91w0h9WTT3 #PCCfunded

11 Mar 2022

Reply Retweet Favourite

New article: PSMA PET/CT guided intensification of therapy in patients at risk of advanced prostate cancer (PATRON): a pragmatic phase III randomized controlled trial https://t.co/6F82hN7mWz #prostatecancer #oncology https://t.co/IKuz4bgsSg

09 Mar 2022

Reply Retweet Favourite

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity.